Ayahuasca has long been used for indigenous healing and spiritual rituals. Now, a Brazilian clinical trial has confirmed that this psychoactive drink can help those with even severe depression.
Academic rigour, journalistic flair
Articles on Psychedelics
Displaying 41 - 50 of 50 articles
Psychedelic drugs have inspired great songs and works of art. But they may also have potential for treating disease like depression and PTSD by helping to regrow damaged regions of the brain.
Shaman have used the psychoactive effects of ayahuasca for spiritual and healing purposes for hundreds of years. But a new breed of tourist has discovered this plant-based drug.
Three experts reveal all.
Humans have a desire to transcend everyday existence. So laws banning psychoactive substances are on a hiding to nothing.
Psychedelia is too often dismissed as a product of the decade and the drugs, but the phenomenon has a far richer history than that of the swinging 60s.
Psychedelic drugs alter consciousness in a profound and novel way that increases the breadth and fluency of cognition. However, until recently, we were unable to offer an explanation for how the brain…
A recent Norwegian study on psychedelic drugs and psychological well-being not only highlighted fewer mental health issues among users of these drugs but also underscored the reinvigoration of scientific…
People who use LSD and other psychedelic drugs show fewer mental health problems, according to a large population-based study. Researchers from the Norwegian University of Science and Technology analysed…
In 1632 the Catholic Church convened a case against Galileo on the grounds that his work using the telescope to explore the nature of the heavens contradicted the church’s teaching - the culmination of…
Job Board
-
Program Manager, Teaching & Learning Initiatives
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Senior Lecturer of Addiction, Edith Cowan University
-
PhD Candidate, Congnitive Neuroscience, University of Toronto
-
PhD student in Clinical Psychology, York University, Canada
-
Distinguished Professor of Neurology and Psychiatry, Director of Psychedelics Division at Neuroscape, University of California, San Francisco
-
Research fellow, Swinburne University of Technology
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Royal Literary Fellow, Lancaster University
-
Associate Professor, Behavioural Pharmacology Research Unit, Johns Hopkins University
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Professor of Psychiatry, Universidade Estadual de Campinas (Unicamp)
-
Senior lecturer, Australian National University
-
Principal Lecturer in Psychology, University of Brighton
-
Professor, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
-
Senior Research Fellow in Cognitive Science, Macquarie University
-
Research Assistant in Psychiatry, University of Cambridge
